Is the US prepared to deal with another pandemic or widespread health crisis?
Short answer: Partly. The U.S. has shored up some core capacities since 2020, but significant gaps and several 2025–2026 policy and funding shifts leave the country unevenly prepared for a fast‑moving pandemic.
What’s stronger now
Where we’re vulnerable
A real‑world stress test
Bottom line
If helpful, I can tailor this to your state or sector (e.g., hospitals, schools, employers) and suggest concrete “next‑pandemic” checklists.
Citations (11)
- ASPR Releases Five-Year Plan to Strengthen Medical Countermeasure Preparedness | ASPR
Backs: “HHS/ASPR published a 2025–2029 multiyear plan for vaccines, drugs, and diagnostics; the National Pre‑pandemic Influenza Vaccine Stockpile maintains H5N1 antigens/adjuvants; and HHS issued new guidance to improve how states coordinate with the Strategic National Stockpile.”
evidence, article, points to yes. Claim: HHS/ASPR published a 2025–2029 multiyear medical countermeasures plan, with the H5N1 stockpile and new guidance on state coordination with the Strategic National Stockpile.
- Data Modernization at CDC | Data Modernization | CDC
Backs: “CDC’s data‑modernization work now incorporates a large wastewater network (1,500+ sites) tracking multiple pathogens, and GAO notes broader federal steps to improve biosurveillance.”
evidence, reference entry, points to yes. Claim: CDC data modernization incorporates a large wastewater network (1,500+ sites) tracking multiple pathogens.
- COVID-19 Vaccines (2025-2026 Formula) for Use in the United States Beginning in Fall 2025 | FDA
Backs: “FDA also confirmed the June 29, 2026 end of COVID‑19 emergency use authorizations, reflecting a more “steady‑state” framework.”
evidence, official document, points to yes. Claim: FDA confirmed the end of COVID-19 emergency use authorizations and routinely updates respiratory-virus products, reflecting a steady-state framework.
- Preparedness for Public Health Emergencies at Risk Amid Federal Funding and Workforce Instability, New Report Finds - TFAH
Backs: “CDC’s FY2026 request holds core PHEP grants at $350M—well below expert recommendations; and GAO flags lingering coordination problems between CDC’s PHEP and ASPR’s Hospital Preparedness Program.”
evidence, article, points to no. Claim: TFAH finds wide variation among states and warns federal workforce and funding disruptions threaten readiness.
- FY 2027 President’s Budget Request: ASPR Highlights | ASPR
Backs: “Even discussing this cut introduces operational risk for hospitals and EMS planning.”
evidence, official document, points to no. Claim: The FY2027 budget proposal would eliminate Hospital Preparedness Program cooperative agreements that fund health-care coalitions for surge events.
- Public Health Data Authority | Data Modernization | CDC
Backs: “CDC still lacks general legal authority to require standardized, real‑time reporting from states and health systems—slowing situational awareness when speed matters most.”
evidence, reference entry, points to no. Claim: CDC lacks general legal authority to require standardized, real-time data reporting from states and health systems.
- Public Health Preparedness: HHS Needs a Coordinated National Approach for Diagnostic Testing for Pandemic Threats | U.S. GAO
Backs: “GAO (June 2025) said HHS needs a coordinated, regularly updated national diagnostic testing strategy for pandemic threats—an Achilles’ heel in early outbreaks.”
evidence, official document, points to no. Claim: GAO (June 2025) said HHS needs a coordinated, regularly updated national diagnostic testing strategy for pandemic threats.
- Fact Sheet: U.S. Withdrawal from the World Health Organization | HHS.gov
Backs: “The U.S. completed its withdrawal from WHO on January 22, 2026, and formally rejected the 2024 International Health Regulations amendments—moves that can limit access to early alerts, common standards, and joint actions in global crises.”
evidence, official document, points to no. Claim: The US completed its WHO withdrawal and rejected the 2024 IHR amendments, which may limit early alerts and joint action.
- HHS Winds Down mRNA Vaccine Development Under BARDA | HHS.gov
Backs: “That may slow rapid, platform‑based countermeasure development during a novel respiratory outbreak.”
evidence, article, points to no. Claim: HHS began winding down BARDA mRNA vaccine investments, possibly slowing rapid platform-based countermeasure development.
- Objective 1: Strategic Implementation and Deployment of the U.S. National Pre-pandemic Influenza Vaccine Stockpile (NPIVS) | ASPR
Backs: “NPIVS doses and surveillance exist, CDC still assesses low risk to the public, but experts have criticized uneven farm‑level tracking and testing—illustrating how policy, data‑sharing, and field operations can still lag.”
evidence, reference entry, neutral. Claim: H5N1 in dairy cattle shows both progress (stockpile doses, surveillance) and gaps in preparedness.
- FY 2026 CDC Congressional Justification
Backs: “Policymakers would improve preparedness by stabilizing PHEP/HPP funding, granting CDC modern data‑reporting authority, sustaining rapid‑platform vaccine R&D, and maintaining strong international technical ties—even outside WHO.”
statistic, official document, points to no. Claim: CDC's FY2026 request holds core PHEP grants at $350M, below expert recommendations; policymakers should stabilize funding.